Tumor Cell-Triggered Macrophage-Mediated Suppression of the T-Cell Cytotoxic Response to Tumor-Associated Antigens. II. Mechanisms for Induction of Suppression

The mechanisms were investigated for the tumor cell-triggered macrophage-induced suppression of T-cell-mediated tumor immunity. Interaction between tumor cells and macrophages triggered the production of prostaglandin(s) (PG) that initiated the suppressor events. In our experiments, PGE, or PGE2 sup...

Full description

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 1982-10, Vol.69 (4), p.873-878
Main Authors: Ting, Chou-Chik, Hargrove, Myrthel E.
Format: Article
Language:English
Subjects:
Animals
Antibody-Dependent Cell Cytotoxicity - drug effects
Antigens, Neoplasm - immunology
Cell Line
Cyclophosphamide - pharmacology
Female
Immune Tolerance
Indomethacin - pharmacology
Interleukin-2 - immunology
Killer Cells, Natural - immunology
Leukemia, Experimental - immunology
Lymphocyte Culture Test, Mixed
Macrophages - drug effects
Macrophages - immunology
Mice
Mice, Inbred C57BL
Prostaglandins - biosynthesis
Prostaglandins - immunology
T-Lymphocytes - immunology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The mechanisms were investigated for the tumor cell-triggered macrophage-induced suppression of T-cell-mediated tumor immunity. Interaction between tumor cells and macrophages triggered the production of prostaglandin(s) (PG) that initiated the suppressor events. In our experiments, PGE, or PGE2 suppressed the generation of cytotoxic T-Iymphocytes in the syngeneic mixed lymphocyte tumor cell cultures. Indomethacin, a PG synthetase inhibitor, blocked the induction of the macrophage-mediated suppression, which suggested that suppression was caused by endogenous PG. This suppression might be further mediated by the generation of suppressor T-cells. Significant reduction in the levels of macrophage-induced suppression was seen in hosts receiving cyclophosphamide treatment, which could eliminate the precursors of suppressor T-cells. These findings indicated that tumor cells may trigger a chain of reactions, through the generation of suppressor factors or suppressor cells, to subvert the host's immune surveillance.
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/69.4.873